| Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage S Caprodossi, R Lucciarini, C Amantini, M Nabissi, G Canesin, P Ballarini, ... European urology 54 (3), 612-620, 2008 | 128 | 2008 |
| Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization G Canesin, EP Cuevas, V Santos, C López-Menéndez, G Moreno-Bueno, ... Oncogene 34 (8), 951-964, 2015 | 107 | 2015 |
| Galectin-3 expression is associated with bladder cancer progression and clinical outcome G Canesin, P Gonzalez-Peramato, J Palou, M Urrutia, C Cordón-Cardo, ... Tumor Biology 31, 277-285, 2010 | 88 | 2010 |
| LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition EP Cuevas, G Moreno-Bueno, G Canesin, V Santos, F Portillo, A Cano Biology open 3 (2), 129-137, 2014 | 72 | 2014 |
| Heme-derived metabolic signals dictate immune responses G Canesin, SM Hejazi, KD Swanson, B Wegiel Frontiers in immunology 11, 509356, 2020 | 65 | 2020 |
| Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model G Canesin, S Evans-Axelsson, R Hellsten, A Krzyzanowska, CP Prasad, ... PLoS One 12 (9), e0184418, 2017 | 65 | 2017 |
| The STAT3 inhibitor galiellalactone effectively reduces tumor growth and metastatic spread in an orthotopic xenograft mouse model of prostate cancer G Canesin, S Evans-Axelsson, R Hellsten, O Sterner, A Krzyzanowska, ... European urology 69 (3), 400-404, 2016 | 58 | 2016 |
| Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis E Englund, G Canesin, KS Papadakos, N Vishnu, E Persson, B Reitsma, ... Oncotarget 8 (58), 98298, 2017 | 53 | 2017 |
| Heme detoxification by heme oxygenase-1 reinstates proliferative and immune balances upon genotoxic tissue injury A Hedblom, SM Hejazi, G Canesin, R Choudhury, KA Hanafy, ... Cell Death & Disease 10 (2), 72, 2019 | 38 | 2019 |
| Scavenging of labile heme by hemopexin is a key checkpoint in cancer growth and metastases G Canesin, A Di Ruscio, M Li, S Ummarino, A Hedblom, R Choudhury, ... Cell reports 32 (12), 2020 | 36 | 2020 |
| Circulating tumor cells as a marker for progression‐free survival in metastatic castration‐naïve prostate cancer A Josefsson, A Linder, D Flondell Site, G Canesin, A Stiehm, A Anand, ... The Prostate 77 (8), 849-858, 2017 | 31 | 2017 |
| Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment … Z Escobar, A Bjartell, G Canesin, S Evans-Axelsson, O Sterner, R Hellsten, ... Journal of Medicinal Chemistry 59 (10), 4551-4562, 2016 | 31 | 2016 |
| STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population G Canesin, V Maggio, M Palominos, A Stiehm, HR Contreras, ... Scientific Reports 10 (1), 13958, 2020 | 23 | 2020 |
| Cytokines and Janus kinase/signal transducer and activator of transcription signaling in prostate cancer: Overview and therapeutic opportunities G Canesin, A Krzyzanowska, R Hellsten, A Bjartell Current Opinion in Endocrine and Metabolic Research 10, 36-42, 2020 | 18 | 2020 |
| Deletion of biliverdin reductase A in myeloid cells promotes chemokine expression and chemotaxis in part via a complement C5a–C5aR1 pathway K Bisht, G Canesin, T Cheytan, M Li, Z Nemeth, E Csizmadia, ... The Journal of Immunology 202 (10), 2982-2990, 2019 | 18 | 2019 |
| HO-1 and heme: G-quadruplex interaction choreograph DNA damage responses and cancer growth G Canesin, AM Muralidharan, KD Swanson, B Wegiel Cells 10 (7), 1801, 2021 | 14 | 2021 |
| A role of the heme degradation pathway in shaping prostate inflammatory responses and lipid metabolism LV Lilljebjörn, E Csizmadia, A Hedblom, G Canesin, A Kalbasi, M Li, ... The American Journal of Pathology 190 (4), 830-843, 2020 | 6 | 2020 |
| Heme oxygenase-1 mitigates liver injury and fibrosis via modulation of LNX1/Notch1 pathway in myeloid cells G Canesin, L Feldbrügge, G Wei, L Janovicova, M Janikova, E Csizmadia, ... Iscience 25 (9), 2022 | 5 | 2022 |
| Labile heme and heme oxygenase-1 maintain tumor-permissive niche for endometriosis-associated ovarian cancer JL Hecht, M Janikova, R Choudhury, F Liu, G Canesin, L Janovicova, ... Cancers 14 (9), 2242, 2022 | 5 | 2022 |
| Measurement of labile and protein-bound heme in fixed prostate cancer cells and in cellular fractions G Canesin, L Janovicova, B Wegiel STAR protocols 2 (2), 100491, 2021 | 4 | 2021 |
